Oskar Axelsson

2PUBLICATIONS
4CO-AUTHORS
Predictive and prognostic markersMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (2)

|Jun 05, 2024
177Lu-SN201 nanoparticle shows superior anti-tumor efficacy over conventional cancer drugs in 4T1 orthotopic model.

Sujinna Lekmeechai, Kristian Pietras, Oskar Axelsson

|Jan 23, 2023
Characterization and Efficacy of a Nanomedical Radiopharmaceutical for Cancer Treatment.

Ingrid Yao Mattisson, Sania Bäckström, Erik Ekengard

Pageof 1